Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

21.69
Delayed Data
As of Jul 22
 +0.02 / +0.09%
Today’s Change
10.55
Today|||52-Week Range
25.93
+36.33%
Year-to-Date
Company News for July 12, 2016
Jul 12 / Zacks.com - Paid Partner Content
Why Wynn Resorts, Lannett, and Sagent Pharmaceuticals Jumped Today
Jul 11 / MotleyFool.com - Paid Partner Content
What Happened in the Stock Market Today
Jul 11 / MotleyFool.com - Paid Partner Content
Why Sagent Pharmaceuticals' Stock Is Soaring Today
Jul 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close21.67
Today’s open21.70
Day’s range21.65 - 21.72
Volume848,178
Average volume (3 months)704,772
Market cap$712.3M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-154.92%
Earnings growth (this year)+142.10%
Earnings growth (next 5 years)+88.75%
Revenue growth (last year)+10.14%
P/E ratioNM
Price/Sales1.62
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...+0.31+0.68%
SGYPSynergy Pharmaceutic...+0.08+2.04%
INSMInsmed Inc-0.11-0.98%
MACKMerrimack Pharmaceut...+0.14+2.61%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$318.3M
Annual profit (last year)-$21.9M
Net profit margin-6.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Allan Oberman
Executive Vice President-
Global Operations
J. Frank Harmon
Corporate headquarters
Schaumburg, Illinois

Forecasts

Partner Offers

Search for Jobs